Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up ...

ORIC's Phase 1b trial of ORIC-944 in mCRPC shows PSA responses and strong tolerability, with Phase 3 trials and financing ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

A biotech company has announced plans to acquire 23andMe after the genetic testing company filed for Chapter 11 bankruptcy.